In vitro selectivity, in vivo biodistribution and tumour uptake of annexin V radiolabelled with a positron emitting radioisotope
2003

Imaging Apoptosis with Radiolabelled Annexin V

Sample size: 3 publication Evidence: moderate

Author Information

Author(s): Collingridge D R, Glaser M, Osman S, Barthel H, Hutchinson O C, Luthra S K, Brady F, Bouchier-Hayes L, Martin S J, Workman P, Price P, Aboagye E O

Primary Institution: Cancer Research UK PET Oncology Group, Imperial College of Science Technology and Medicine

Hypothesis

Can iodinated-annexin V be used to detect apoptosis in tumors?

Conclusion

Iodinated annexin V can be used to detect chemotherapy-induced apoptosis in vitro and in tumor-bearing mice.

Supporting Evidence

  • The study demonstrated that radiolabelled annexin V binds specifically to apoptotic cells.
  • In vivo studies showed increased uptake of annexin V in tumors treated with chemotherapy.
  • Statistical analysis indicated significant differences in binding between treated and control cells.

Takeaway

This study shows that a special protein can help doctors see if cancer cells are dying after treatment, which is important for understanding how well the treatment is working.

Methodology

The study involved radiolabelling annexin V and testing its binding to apoptotic cells in vitro and in vivo using PET imaging.

Potential Biases

Potential for binding to necrotic cells, which could confound results.

Limitations

The study did not detect tumors by PET imaging, and high uptake in kidneys may affect quantification.

Participant Demographics

C3H/Hej mice bearing RIF-1 tumors.

Statistical Information

P-Value

0.0001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6601262

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication